Per policy, orders for these non-formulary agents will be changed to formulary equivalents.
Non-Formulary Agent
Formulary Equivalent
nabumetone (Relafen) 1,000 mg daily
naproxen (Naprosyn) 500 mg BID
nabumetone (Relafen) 1,500 mg or 2,000 mg daily
naproxen (Naprosyn) 500 mg TID
Anticoagulant / Antiplatelet Stoppage For Procedures
generic (Brand)
Dept.
Procedure Type (hover over entry for examples)
Stop Medication Prior To Procedure Restart after:
nabumetone (Relafen)
Anesthesia
High-risk
6 days Restart after 24 hours
Intermediate-risk
No hold Restart after 24 hours
Low-risk
No hold Restart after 24 hours
Patients with high risk of bleeding (eg, old age, history of bleeding tendency, concurrent uses of other anticoagulants/antiplatelets, liver cirrhosis or advanced liver disease, and advanced renal disease) undergoing low- or intermediate-risk procedures should be treated as intermediate or high risk, respectively.
Radiology
Invasive Procedures
48-72 hours
Paracentesis/Thoracentesis
No hold
Surgery
High-risk
7 days Restart after 24 hours
Low-risk
No Hold Restart after 24 hours
Enteral Drug Administration notes.
Generic (Brand)
Comments and Considerations
Recommendations for Administration with Enteral Nutrition
(hover over entry for examples)
(Relafen)
(Brand)
(Relafen)